Skip to main content
Clinical Trials/CTRI/2018/08/015275
CTRI/2018/08/015275
Completed
未知

Role of vitamin E supplementation in treatment resistant epilepsy in children in the age group 1-12 years

Muhammed Shabeer P0 sites32 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- EpilepsyHealth Condition 2: G40- Epilepsy and recurrent seizuresHealth Condition 3: G404- Other generalized epilepsy and epileptic syndromes
Sponsor
Muhammed Shabeer P
Enrollment
32
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 30, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Muhammed Shabeer P

Eligibility Criteria

Inclusion Criteria

  • Age 1\-12 years
  • Diagnosis of treatment resistant epilepsy
  • A) Recieving any of at least two anti convulsant drugs for past 6 months
  • B) at least 3 seizures in last 6 months
  • C) the ability of family or friends to count the number of seizures in epileptic patients during the determined period

Exclusion Criteria

  • Neuroimaging suggestive of mass lesion
  • Receiving vitamin E supplementation within 6 months of study
  • Presence of live and kidney disease

Outcomes

Primary Outcomes

Not specified

Similar Trials